AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Amicus Therapeutics Statistics
Share Statistics
Amicus Therapeutics has 298.81M shares outstanding. The number of shares has increased by 1.16% in one year.
Shares Outstanding | 298.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.75% |
Owned by Institutions (%) | n/a |
Shares Floating | 290.29M |
Failed to Deliver (FTD) Shares | 14.34K |
FTD / Avg. Volume | 0.55% |
Short Selling Information
The latest short interest is 19.60M, so 6.56% of the outstanding shares have been sold short.
Short Interest | 19.60M |
Short % of Shares Out | 6.56% |
Short % of Float | 6.73% |
Short Ratio (days to cover) | 7.44 |
Valuation Ratios
The PE ratio is -27.63 and the forward PE ratio is 65.56.
PE Ratio | -27.63 |
Forward PE | 65.56 |
PS Ratio | 10.49 |
Forward PS | 3.4 |
PB Ratio | 26.15 |
P/FCF Ratio | -54.73 |
PEG Ratio | n/a |
Enterprise Valuation
Amicus Therapeutics Inc. has an Enterprise Value (EV) of 4.39B.
EV / Earnings | -28.94 |
EV / Sales | 10.98 |
EV / EBITDA | -47.64 |
EV / EBIT | -59.68 |
EV / FCF | -57.32 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 2.78.
Current Ratio | 2.88 |
Quick Ratio | 2.52 |
Debt / Equity | 2.78 |
Total Debt / Capitalization | 73.54 |
Cash Flow / Debt | -0.16 |
Interest Coverage | -1.47 |
Financial Efficiency
Return on equity (ROE) is -0.95% and return on capital (ROIC) is -12.26%.
Return on Equity (ROE) | -0.95% |
Return on Assets (ROA) | -0.19% |
Return on Capital (ROIC) | -12.26% |
Revenue Per Employee | 798.71K |
Profits Per Employee | -303.17K |
Employee Count | 500 |
Asset Turnover | 0.51 |
Inventory Turnover | 0.63 |
Taxes
Income Tax | 1.48M |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -27.59% in the last 52 weeks. The beta is 0.67, so Amicus Therapeutics 's price volatility has been higher than the market average.
Beta | 0.67 |
52-Week Price Change | -27.59% |
50-Day Moving Average | 9.95 |
200-Day Moving Average | 10.48 |
Relative Strength Index (RSI) | 39.84 |
Average Volume (20 Days) | 2.60M |
Income Statement
In the last 12 months, Amicus Therapeutics had revenue of 399.36M and earned -151.58M in profits. Earnings per share was -0.51.
Revenue | 399.36M |
Gross Profit | 362.03M |
Operating Income | -73.49M |
Net Income | -151.58M |
EBITDA | -92.08M |
EBIT | -73.49M |
Earnings Per Share (EPS) | -0.51 |
Balance Sheet
The company has 246.99M in cash and 445.06M in debt, giving a net cash position of -198.06M.
Cash & Cash Equivalents | 246.99M |
Total Debt | 445.06M |
Net Cash | -198.06M |
Retained Earnings | -2.68B |
Total Assets | 786.56M |
Working Capital | 340.34M |
Cash Flow
In the last 12 months, operating cash flow was -69.09M and capital expenditures -7.44M, giving a free cash flow of -76.53M.
Operating Cash Flow | -69.09M |
Capital Expenditures | -7.44M |
Free Cash Flow | -76.53M |
FCF Per Share | -0.26 |
Margins
Gross margin is 90.65%, with operating and profit margins of -18.4% and -37.96%.
Gross Margin | 90.65% |
Operating Margin | -18.4% |
Pretax Margin | -37.59% |
Profit Margin | -37.96% |
EBITDA Margin | -23.06% |
EBIT Margin | -18.4% |
FCF Margin | -19.16% |
Dividends & Yields
FOLD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -5.54% |
FCF Yield | -2.78% |
Analyst Forecast
The average price target for FOLD is $17, which is 84.6% higher than the current price. The consensus rating is "Buy".
Price Target | $17 |
Price Target Difference | 84.6% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Scores
Altman Z-Score | -1.06 |
Piotroski F-Score | 5 |